An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% With antioxidants for the treatment of hyperpigmentation

Cutis

Volumn 81, Issue 4, 2008, Pages 365-371

  Cook Bolden, Fran E ^a,b,d,e   Hamilton, Saonjie F ^c  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Skin Specialty Group   (United States)

^c Skin Specialty Group

^d SkinMedica Inc

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HYDROQUINONE DERIVATIVE; RETINOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HUMAN; MALE; MELANOSIS; MIDDLE AGED; NONPARAMETRIC TEST; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTIOXIDANTS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; HUMANS; HYDROQUINONES; MALE; MELANOSIS; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VITAMIN A;

EID: 43249100534     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)